Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

Conditions: Liver Transplant Interventions: Drug: Everolimus; Drug: Tacrolimus (continued reduction); Drug: Tacrolimus (maintain 50% reduction); Drug: Everolimus Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting

https://clinicaltrials.gov/study/NCT06280950

Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials